Sanger or dideoxy sequencing has remained the most commonly used DNA sequencing technique up until
recently, and was instrumental in sequencing genomes of model organisms including Humans, Drosophila
However, with advances made in the fields of microfluidics, nanotechnology and informatics, nowadays, alternate sequencing
technologies also known as the 'NextGen' sequencing technologies are gaining popularity. The term 'NextGen' sequencing is used
to collectively describe technologies other than Sanger sequencing that have the capability
of producing increased sequencing depth and coverage at a fraction of time, labor, and cost. Currently, these technologies
include the 454 GS20 pyrosequencing technology
(Roche Applied Science),
Genome Analyzer IIx
(Applied Biosystems), and the
Heliscope Single Molecule Sequencer
(Helicos, Inc.). In addition to Sanger sequencing, since December 2008, CCG has initiated facilitation of next generation
sequencing projects. We have completed over a dozen 454 sequencing projects
and several other deep sequencing projects are in the pipeline.
1/26/2012 - Currently, we have samples occupying 2 lanes for 1x36 bp or 1x75 bp sequencing.
If you are interested in submitting samples for the above queue(s), contact Gery Hehman